New Age Beverages Corporation NBEV is slated to report first-quarter 2019 results on May 9, before market open.
For the first quarter, the Zacks Consensus Estimate is pegged at a loss of 2 cents compared with a loss of 7 cents incurred in the year-ago quarter. Notably, the estimates remained stable over the past 30 days. For quarterly revenues, the consensus mark stands at $59.6 million, indicating significant improvement from the year-ago quarter number.
Factors at Play
New Age Beverages is benefiting from strength in its portfolio of brands. This also includes the enhancement cannabis-infused beverage portfolio, where management believes to seizure first-mover advantage. Additionally, the company is on track to expand its core brand portfolio. The company is likely to gain from its strategic buyouts such as the Morinda acquisition. Notably, it has completed the integration of the Morinda acquisition in December last year.
Furthermore, New Age Beverages has been strengthening its foothold in the e-commerce distribution system. Presently, it annually ships above $150 million of product via this system, and intends to integrate this with New and Age. As a result, the company will expand to e-tail and other e-tail systems, enhance subscriber base and database as well as build affiliates internally and externally.
All these aforementioned growth drivers are likely to boost the company’s top and bottom line in the first quarter.
Conversely, New Age Beverages has been recovering from inventory shortfalls mainly owing to working capital issues. This adversely impacted the underlying strength of the company. This is likely to be a hindrance while capturing growth opportunities and might affect the company’s results in the quarter to be reported. Also, higher operating expenses are likely to weigh on the company’s profitability.
Our proven model does not conclusively show that New Age Beverages is likely to beat estimates in the first quarter. This is because a stock needs to have both — a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) — for this to happen. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
New Age Beverage Corporation Price and EPS Surprise
New Age Beverage Corporation Price and EPS Surprise | New Age Beverage Corporation Quote
Although New Age Beverages’ Zacks Rank #2 increases the predictive power of earnings beat, its Earnings ESP of 0.00% makes surprise prediction difficult.
Stocks Likely to Beat Earnings Estimates
Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat in the upcoming releases:
WD-40 Company WDFC has an Earnings ESP of +4.13% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Ollie's Bargain Outlet Holdings, Inc. OLLI has an Earnings ESP of +1.61% and a Zacks Rank #3.
Keurig Dr Pepper KDP has an Earnings ESP of +1.08% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ollie's Bargain Outlet Holdings, Inc. (OLLI) : Free Stock Analysis Report
WD-40 Company (WDFC) : Free Stock Analysis Report
Keurig Dr Pepper, Inc (KDP) : Free Stock Analysis Report
New Age Beverage Corporation (NBEV) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research